A Global Rank End Point for Clinical Trials in Acute Heart Failure

被引：66

作者：

Felker, G. Michael ^{[1
]}

Maisel, Alan S. ^{[2
]}

机构：

[1] Duke Clin Res Inst, Durham, NC 27705 USA

[2] Univ Calif San Diego, San Diego, CA 92103 USA

来源：

CIRCULATION-HEART FAILURE | 2010年 / 3卷 / 05期

关键词：

heart failure; clinical trials; natriuretic peptides; WORSENING RENAL-FUNCTION; CARDIAC TROPONIN-T; NATRIURETIC PEPTIDE; PROGNOSTIC VALUE; HOSPITAL DISCHARGE; NT-PROBNP; TOLVAPTAN; THERAPIES; ADMISSION;

D O I：

10.1161/CIRCHEARTFAILURE.109.926030

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：643 / 646

页数：4

共 36 条

[1]

End Points for Clinical Trials in Acute Heart Failure Syndromes [J].

Allen, Larry A. ;

Hernandez, Adrian F. ;

O'Connor, Christopher M. ;

Felker, G. Michael .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (24) :2248-2258

[2]

A translational approach to detecting drug-induced cardiac injury with cardiac troponins: Consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute [J].

Berridge, Brian R. ;

Pettit, Syril ;

Walker, Dana B. ;

Jaffe, Alan S. ;

Schultze, Albert E. ;

Herman, Eugene ;

Reagan, William J. ;

Lipshultz, Steven E. ;

Apple, Fred S. ;

York, Malcolm J. .

AMERICAN HEART JOURNAL, 2009, 158 (01) :21-29

[3]

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J].

Bettencourt, P ;

Azevedo, A ;

Pimenta, J ;

Frioes, F ;

Ferreira, S ;

Ferreira, A .

CIRCULATION, 2004, 110 (15) :2168-2174

[4]

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients [J].

Butler, J ;

Forman, DE ;

Abraham, WT ;

Gottlieb, SS ;

Loh, E ;

Massie, BM ;

O'Connor, CM ;

Rich, MW ;

Stevenson, LW ;

Wang, YF ;

Young, JB ;

Krumholz, HM .

AMERICAN HEART JOURNAL, 2004, 147 (02) :331-338

[5]

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE [J].

Cleland, JGF ;

Freemantle, N ;

Coletta, AP ;

Clark, AL .

EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (01) :105-110

[6]

Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure [J].

Cohen-Solal, Alain ;

Logeart, Damien ;

Huang, Bidan ;

Cai, Danlin ;

Nieminen, Markku S. ;

Mebazaa, Alexandre .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (25) :2343-2348

[7]

The pathophysiology of acute heart failure - Is it all about fluid accumulation? [J].

Cotter, Gad ;

Felker, G. Michael ;

Adams, Kirkwood F. ;

Milo-Cotter, Olga ;

O'Connor, Christopher M. .

AMERICAN HEART JOURNAL, 2008, 155 (01) :9-18

[8]

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure [J].

Damman, Kevin ;

van Veldhuisen, Dirk J. ;

Navis, Gerjan ;

Voors, Adriaan A. ;

Hillege, Hans L. .

EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (10) :997-1000

[9]

Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure [J].

Del Carlo, CH ;

Pereira-Barretto, AC ;

Cassaro-Strunz, C ;

Latorre, MDDO ;

Ramires, JAF .

JOURNAL OF CARDIAC FAILURE, 2004, 10 (01) :43-48

[10]

Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial [J].

Dunlay, Shannon M. ;

Gheorghiade, Mihai ;

Reid, Kimberly J. ;

Allen, Larry A. ;

Chan, Paul S. ;

Hauptman, Paul J. ;

Zannad, Faiez ;

Maggioni, Aldo P. ;

Swedberg, Karl ;

Konstam, Marvin A. ;

Spertus, John A. .

EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (04) :367-374

← 1 2 3 4 →